ONCT

Oncternal Therapeutics, Inc. Common Stock
ONCT

Overview Fund Trends Analyst Outlook Journalist POV
Delisted

ONCT was delisted on the 2nd of December, 2024.

Back to rankings

48 hedge funds and large institutions have $4.66M invested in Oncternal Therapeutics, Inc. Common Stock in 2018 Q3 according to their latest regulatory filings, with 18 funds opening new positions, 16 increasing their positions, 4 reducing their positions, and 25 closing their positions.

New
Increased
Maintained
Reduced
Closed

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

less funds holding

Funds holding: →

less first-time investments, than exits

New positions opened: | Existing positions closed:

less call options, than puts

Call options by funds: $ | Put options by funds: $

96% less capital invested

Capital invested by funds: $104M → $4.66M (-$99.8M)

100% less funds holding in top 10

Funds holding in top 10: 1 → 0 (-1)

Holders
48
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$540K
Puts
$1.32M
Net Calls
Net Calls Change

Top Buyers

1
+$431K
2
+$410K
3
+$322K
4
Geode Capital Management
Geode Capital Management
Massachusetts
+$299K
5
Millennium Management
Millennium Management
New York
+$291K

Top Sellers

1
-$23M
2
-$20.1M
3
-$13M
4
BI
BVF Inc
California
-$5.91M
5
RSCM
Rock Springs Capital Management
Maryland
-$5.42M
Name Holding Trade Value Shares
Change 		Change in
Stake
26
$12K
27
$11K
28
$10K
29
$9K
30
$5K
31
$4K
32
$4K
33
$4K
34
$3K
35
$3K
36
$3K
37
$2K
38
$2K
39
$1K
40
$1K
41
$1K
42
$1K
43
$283
44
$237
45
–
46
–
47
–
48
–
49
–
50
–
1
2
3